// App-Quantinova.ai

: Protocol to identify potential severe asthma in UK primary care

Researchers

Presenter

  • Heath Heatley

Principal Investigators

  • Victoria Carter

  • Isha Chaudhry

  • Naeimeh Hosseini

  • Ruth Murray

  • Sinthia Bosnic-Anticevich

  • Liam Heaney

  • David Jackson

  • Rupert Jones

  • Andrew Menzies-Gow

  • Paul Pfeffer

  • John Busby

  • Alan Kaplan

  • Eric Van Ganse

  • Manon Belhassen

  • Chin-Kook Rhee

  • Dermot Ryan

  • Arnaud Bourdin

  • Peter G Gibson

  • Trung N Tran

  • J. Mark Fitzgerald

  • Mona Al-Aahmad

  • Vibeke Backer

  • David Price

Medical Centers

  • Optimum Patient Care, Cambridge, United Kingdom,

  • Woolcock Institute of Medical Research, University of Sydney; Sydney Local Health District, Sydney, Australia

  • UK Severe Asthma and National Registry, Queen’s University Belfast, Belfast, United Kingdom

  • Guy’s and St Thomas’ NHS Trust and King’s College London, London, United Kingdom

  • Faculty of Medicine and Dentistry, University of Plymouth, Plymouth, United Kingdom

  • UK Severe Asthma Network and National Registry, Royal Brompton & Hareï¬eld NHS Foundation Trust, London, United Kingdom,

  • UK Severe Asthma Network; Barts Health NHS Trust and Queen Mary University of London, London, United Kingdom

  • UK Severe Asthma and National Registry, Queen’s University Belfast, Belfast, United Kingdom

  • Family Physician Airways Group of Canada, University of Toronto, Toronto, ON, Canada.

  • Pharmaco-Epidemiology Lyon, HESPER, Claude Bernard University, Lyon, France

  • Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary`s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of.

  • Primary Care Interest Group at European Academy of Allergy and Clinical Immunology, University of Edinburgh, Edinburgh, United Kingdom

  • Department of Respiratory Diseases, Montpellier University Hospitals, Arnaud de Villeneuve Hospital, Montpellier Cedex, France

  • Australian Severe Asthma Network, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia,

  • AstraZeneca, Gaithersberg, MD, United States,

  • The Institute for Heart Lung Health, Vancouver, Canada

  • Al-Rashed Allergy Center, Ministry of Health, Microbiology Department, Faculty of Medicine, Kuwait University, Kuwait, Kuwait

  • Department of Respiratory Medicine, Bispebjerg University Hospital, Copenhagen University, Copenhagen, Denmark,

Locations

  • United Kingdom

  • Australia

  • Canada

  • France

  • Republic of South Korea

  • United States

  • Kuwait

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved